In-stent stenosis: pathology and implications for the development of drug eluting stents.

Over 1.5 million percutaneous coronary revascularisation procedures are performed annually world wide, most being intracoronary stenting. Despite enormous advances in devices, the major limitation is in-stent stenosis (ISS) (reviewed by Bennett and O’Sullivan). Although ISS rates are 10–20% in selected patients, we now stent total occlusions, saphenous vein… CONTINUE READING